Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers

por Petry, Karl Ulrich, Liebrich, Clemens, Luyten, Alexander, Zander, Martina, Iftner, Thomas
Publicado 2017

Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany

por Petry, Karl Ulrich, Luyten, Alexander, Justus, Annika, Iftner, Angelika, Strehlke, Sarah, Schulze-Rath, Renate, Iftner, Thomas
Publicado 2012

Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany

por Horn, Johannes, Denecke, Agnieszka, Luyten, Alexander, Rothe, Beate, Reinecke-Lüthge, Axel, Mikolajczyk, Rafael, Petry, Karl Ulrich
Publicado 2019

Annual Papanicolaou screening for 5 years among human papillomavirus-negative women

por Petry, Karl Ulrich, Rinnau, Franziska, Böhmer, Gerd, Hollwitz, Bettina, Luyten, Alexander, Buttmann, Nina, Brünger, Martin, Iftner, Thomas
Publicado 2013

Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis

por Denecke, Agnieszka, Iftner, Thomas, Iftner, Angelika, Riedle, Sebastian, Ocak, Marion, Luyten, Alexander, Üye, Isak, Tunc, Kübra, Petry, Karl Ulrich
Publicado 2021

Evaluating HPV‐negative CIN2+ in the ATHENA trial

por Petry, Karl Ulrich, Cox, J. Thomas, Johnson, Kristin, Quint, Wim, Ridder, Ruediger, Sideri, Mario, Wright, Thomas C., Behrens, Catherine M.
Publicado 2016

Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Ge...

por Petry, Karl Ulrich, Luyten, Alexander, Justus, Annika, Iftner, Angelika, Strehlke, Sarah, Reinecke-Lüthge, Axel, Grunwald, Elisabeth, Schulze-Rath, Renate, Iftner, Thomas
Publicado 2013

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany

por Sroczynski, Gaby, Schnell-Inderst, Petra, Mühlberger, Nikolai, Lang, Katharina, Aidelsburger, Pamela, Wasem, Jürgen, Mittendorf, Thomas, Engel, Jutta, Hillemanns, Peter, Petry, Karl Ulrich, Krämer, Alexander, Siebert, Uwe
Publicado 2010

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine

por Petry, Karl-Ulrich, Bollaerts, Kaatje, Bonanni, Paolo, Stanley, Margaret, Drury, Rosybel, Joura, Elmar, Kjaer, Susanne K., Meijer, Chris J. L. M., Riethmuller, Didier, Soubeyrand, Benoit, Van Damme, Pierre, Bosch, Xavier
Publicado 2018

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

por Dillner, Joakim, Rebolj, Matejka, Birembaut, Philippe, Petry, Karl-Ulrich, Szarewski, Anne, Munk, Christian, de Sanjose, Silvia, Naucler, Pontus, Lloveras, Belen, Kjaer, Susanne, Cuzick, Jack, van Ballegooijen, Marjolein, Clavel, Christine, Iftner, Thomas
Publicado 2008

Intra‐ and inter‐laboratory agreement of the FAM19A4/mir124‐2 methylation test: Results from an international study

por Floore, Arno, Hesselink, Albertus, Oštrbenk, Anja, Alcaniz, Elia, Rothe, Beate, Pedersen, Helle, Torres Hortal, Montserrat, Doorn, Saskia, Quint, Wim, Petry, Karl Ulrich, Poljak, Mario, Cuschieri, Kate, Bonde, Jesper, de Sanjosé, Silvia, Bleeker, Maaike, Heideman, Daniëlle
Publicado 2019

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

por Bonde, Jesper, Floore, Arno, Ejegod, Ditte, Vink, Frederique J., Hesselink, Albertus, van de Ven, Peter M., Valenčak, Anja Oštrbenk, Pedersen, Helle, Doorn, Saskia, Quint, Wim G., Petry, Karl Ulrich, Poljak, Mario, Stanczuk, Grazyna, Cuschieri, Kate, de Sanjosé, Silvia, Bleeker, Maaike, Berkhof, Johannes, Meijer, Chris J. L. M., Heideman, Daniëlle A. M.
Publicado 2020

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial

por Huang, Li-Min, Puthanakit, Thanyawee, Cheng-Hsun, Chiu, Ren-Bin, Tang, Schwarz, Tino, Pellegrino, Angelo, Esposito, Susanna, Frenette, Louise, McNeil, Shelly, Durando, Paolo, Rheault, Paul, Giaquinto, Carlo, Horn, Michael, Petry, Karl Ulrich, Peters, Klaus, Azhar, Toma, Hillemanns, Peter, De Simoni, Stephanie, Friel, Damien, Pemmaraju, Suryakiran, Hezareh, Marjan, Thomas, Florence, Descamps, Dominique, Folschweiller, Nicolas, Struyf, Frank
Publicado 2017

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

por Vink, Frederique J., Meijer, Chris J.L.M., Clifford, Gary M., Poljak, Mario, Oštrbenk, Anja, Petry, Karl Ulrich, Rothe, Beate, Bonde, Jesper, Pedersen, Helle, de Sanjosé, Silvia, Torres, Montserrat, del Pino, Marta, Quint, Wim G.V., Cuschieri, Kate, Boada, Elia Alcañiz, van Trommel, Nienke E., Lissenberg‐Witte, Birgit I., Floore, Arno N., Hesselink, Albertus T., Steenbergen, Renske D.M., Bleeker, Maaike C.G., Heideman, Daniëlle A.M.
Publicado 2019

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

por Hoyer, Heike, Mehlhorn, Grit, Scheungraber, Cornelia, Hagemann, Ingke, Hirchenhain, Christine, Woelber, Linn, Stolte, Claudia, Hampl, Monika, Scherbring, Sarah, Denecke, Agnieszka, Bartels, Janina, Ebert, Andreas D., Meneder, Sabina, Petzold, Annett, Heller, Tabitha, Heidtke, Karsten R., Schwarz, Elisabeth, Stübs, Frederik, Schütze, Stefanie, Stange, Eva-Lena, Jaeger, Anna, Martignoni, Franca, Dellmann, Ansgar, Rody, Achim, Hillemanns, Peter, Fehm, Tanja, Petry, Karl-Ulrich, Böhmer, Gerd, Schmalfeldt, Barbara, Wimberger, Pauline, Beckmann, Matthias W., Runnebaum, Ingo B., Dürst, Matthias
Publicado 2021